Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.99B |
| 2 |
Apple
AAPL
|
+$2.23B |
| 3 |
NVIDIA
NVDA
|
+$1.92B |
| 4 |
Amazon
AMZN
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altair Engineering Inc
ALTR
|
+$152M |
| 2 |
Merck
MRK
|
+$142M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$141M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$132M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 11.04% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NIU
3876
Niu Technologies
NIU
$193M
| $182K | ﹤0.01% |
44,613
-14,023
| -24% | -$34.9K |
|
|
BCYC
3877
Bicycle Therapeutics
BCYC
$292M
| $181K | ﹤0.01% |
21,377
-17,438
| -45% | -$205K |
|
3878
Bridgford Foods
BRID
$56.5M
| $181K | ﹤0.01% |
22,567
-1,520
| -6% | -$15.5K |
|
3879
Curis
CRIS
$7.83M
| $181K | ﹤0.01% |
4,317
+161
| +4% | +$9.97K |
|
3880
System1
SST
$17.5M
| $181K | ﹤0.01% |
47,489
+138
| +0.3% | +$847 |
|
3881
NanoViricides
NNVC
$36.2M
| $181K | ﹤0.01% |
154,590
+11,277
| +8% | +$14.3K |
|
3882
NextPlat
NXPL
$17.4M
| $181K | ﹤0.01% |
21,743
+5,197
| +31% | +$54.1K |
|
3883
Bridgeline Digital
BLIN
$14.4M
| $180K | ﹤0.01% |
121,667
+31,327
| +35% | +$51.8K |
|
|
API
3884
Agora
API
$377M
| $179K | ﹤0.01% |
44,412
-8,205
| -16% | -$42.8K |
|
3885
Bioceres Crop Solutions
BIOX
$22M
| $178K | ﹤0.01% |
38,927
| – | – |
|
3886
PEDEVCO
PED
$141M
| $176K | ﹤0.01% |
12,588
+97
| +0.8% | +$1.51K |
|
|
KAZR
3887
Skyline Builders Group
KAZR
$57M
| $175K | ﹤0.01% |
+16,786
| New | +$139K |
|
3888
StealthGas
GASS
$319M
| $175K | ﹤0.01% |
30,948
| – | – |
|
3889
PharmaCyte Biotech
PMCB
$6.34M
| $174K | ﹤0.01% |
138,935
-25,801
| -16% | -$41.9K |
|
3890
CEL-SCI Corp
CVM
$30.1M
| $174K | ﹤0.01% |
25,097
+6,014
| +32% | +$65.1K |
|
|
UBX
3891
DELISTED
Unity Biotechnology
UBX
| $173K | ﹤0.01% |
166,213
+6,806
| +4% | +$12.3K |
|
3892
BTCS Inc
BTCS
$55.3M
| $172K | ﹤0.01% |
114,545
+16,526
| +17% | +$40.4K |
|
3893
ESS Tech
GWH
$18.9M
| $170K | ﹤0.01% |
52,097
+2,299
| +5% | +$10.5K |
|
3894
Critical Metals Corp
CRML
$1.06B
| $170K | ﹤0.01% |
122,128
+15,094
| +14% | +$68.8K |
|
3895
Lesaka Technologies
LSAK
$420M
| $168K | ﹤0.01% |
35,318
| – | – |
|
3896
AudioCodes
AUDC
$253M
| $168K | ﹤0.01% |
17,801
| – | – |
|
3897
BioAtla
BCAB
$5.74M
| $166K | ﹤0.01% |
9,585
+1,185
| +14% | +$25.3K |
|
|
TDAC
3898
Translational Development Acquisition Corp
TDAC
$238M
| $166K | ﹤0.01% |
+16,486
| New | +$166K |
|
3899
Serina Therapeutics
SER
$36M
| $166K | ﹤0.01% |
29,206
+3,010
| +11% | +$14.2K |
|
|
SVII
3900
DELISTED
Spring Valley Acquisition Corp II
SVII
| $165K | ﹤0.01% |
14,356
+1,686
| +13% | +$19.2K |
|
Similar funds
Geode Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Geode Capital Management held 4,591 positions worth $1.27T, down 1.4% from $1.29T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Geode Capital Management deployed $47.9B of net new capital in Q1 2025, opening 122 new positions and adding to 3,780 existing holdings. Its largest new stake was Sandisk: 1,936,245 shares worth $92.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $142M trimmed.
- Geode Capital Management's largest Q1 2025 buy was Sandisk: 1,936,245 shares worth $92.2M.
- Geode Capital Management added most to Microsoft in Q1 2025, an estimated $2.99B increase.
- Geode Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $142M.
- Geode Capital Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $152M.
- Geode Capital Management's ten largest holdings make up 29% of its $1.27T portfolio in Q1 2025.
- Geode Capital Management opened 122 new positions and closed 115 in Q1 2025.
- Geode Capital Management's portfolio value fell 1.4% quarter-over-quarter to $1.27T.
Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.